Scale -


  • Revenue is 75.29 Rs Cr; Annual Growth is 29 %; Continuous Growth over 3 years; 5 Year CAGR is 17 %
  • Ebitda is 14.51 Rs Cr; Annual Growth is 55 %; Continuous Growth over 3 years; 5 Year CAGR is 59 %
  • PBT is N/A Rs Cr; Annual Growth is 50 %; 5 Year CAGR is 57 %
  • PAT is 13.03 Rs Cr; Annual Growth is 51 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 72 %

Profitability -


  • PBDIT Margin is 19.27 %; Annual Growth is 20 %; in Top Quartile; 5 Year CAGR is 36 %
  • PAT Margin is 17.31 %; Annual Growth is 17 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 48 %

Return -


  • ROCE is 18.78 %; in Top Quartile; Annual Decline is -32 %; Continuous Decline over 3 years; 5 Year CAGR is -36 %
  • ROA is 13.68 %; in Top Quartile; Annual Decline is -36 %
  • ROE is 18.3 %; in Top Quartile; Annual Decline is -35 %; 5 Year CAGR is -30 %
  • Asset Turnover is 111 %; Annual Decline is -40 %

Efficiency -


  • Operating cash flow is -1.28 Rs Cr; Annual Growth is 78 %
  • Quick Ratio is 3.21; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 42 %
  • Current Ratio is 4.71; in Top Quartile; 5 Year CAGR is 50 %

Solvancy -


  • Debt/Equity is 0.09; Annual Decline is -47 %; Continuous Decline over 3 years; 5 Year CAGR is -38 %
  • Long term Debt is 5.02 Rs Cr; Annual Growth is 92 %; Continuous Growth over 3 years
  • Total Debt is 6.64 Rs Cr; Annual Growth is 31 %; Continuous Growth over 3 years; 5 Year CAGR is 54 %
  • Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -


  • Operating cashflow/ebitda is -9 %; Annual Growth is 86 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is -10 %; Annual Growth is 85 %; Continuous Growth over 3 years
  • Other Expenses/Total Expenses is 9 %; Continuous Decline over 3 years
  • Change in Inventories/Total Expenses is -17 %; in Bottom Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Speciality Medicines Ltd. Estimates – BSE:SPML
Compare with
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Speciality Medicines Upper Circuit Today: Price, Data and Peers